SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000929638-23-000793
Filing Date
2023-03-02
Accepted
2023-03-02 16:56:47
Documents
1
Group Members
NSV PARTNERS III GP, LLCNSV PARTNERS III, LPSOMASUNDARAM SUBRAMANIAM

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 schedule13da.htm SC 13D/A 140350
  Complete submission text file 0000929638-23-000793.txt   141966
Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Subject) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92974 | Film No.: 23700001
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 500 WEST PUTNAM AVE SUITE 400 GREENWICH CT 06830
Business Address 500 WEST PUTNAM AVE SUITE 400 GREENWICH CT 06830 2126885100
NSV Investments I, L.P. (Filed by) CIK: 0001889184 (see all company filings)

IRS No.: 352613353 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A